-
Minisola S, Cipriani C, Colangelo L, Pepe J, et al.
Bone loss after discontinuation of denosumab: the devil is in the details. J Bone Miner Res 2024;39:3-7.
-
Qaseem A, Andrews RA, Campos K, Goldzweig CL, et al.
Quality Indicators for Major Depressive Disorder in Adults: A Review of
Performance Measures by the American College of Physicians. Ann Intern Med 2024;177:507-513.
-
Christensen RH, Ashina H, Al-Khazali HM, Zhang Y, et al.
Differences in Cortical Morphology in People With and Without Migraine: A
Registry for Migraine (REFORM) MRI Study. Neurology 2024;102:e209305.
-
Robblee J, Hakim SM, Reynolds JM, Monteith TS, et al.
Nonspecific oral medications versus anti-calcitonin gene-related peptide
monoclonal antibodies for migraine: A systematic review and meta-analysis of
randomized controlled trials. Headache 2024.
-
Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, et al.
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I:
Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2024.
|